Cargando…
Cytokine production in Ancylostoma duodenale infection
Cytokine response to Ancylostoma duodenale (A. duodenale) infection was measured after starting treatments with piperazine. This study aims to determine the impact of cytokine production after infection with A. duodenale before and after treatment with piperazine. Blood and stool samples of 50 patie...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Carol Davila University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126450/ https://www.ncbi.nlm.nih.gov/pubmed/35646178 http://dx.doi.org/10.25122/jml-2021-0383 |
_version_ | 1784712132115300352 |
---|---|
author | Shlash, Shaimaa Abdulhussein Alzubaidi, Zubaida Falih Saleh, Huda Ali |
author_facet | Shlash, Shaimaa Abdulhussein Alzubaidi, Zubaida Falih Saleh, Huda Ali |
author_sort | Shlash, Shaimaa Abdulhussein |
collection | PubMed |
description | Cytokine response to Ancylostoma duodenale (A. duodenale) infection was measured after starting treatments with piperazine. This study aims to determine the impact of cytokine production after infection with A. duodenale before and after treatment with piperazine. Blood and stool samples of 50 patients with A. duodenale infection and 28 healthy individuals (control) were collected. In this study, IFNγ, IL-5, IL-12, and IL-13 in serum (using ELISA-based methods) were measured. Stool samples were examined using the Kato-Katz technique to detect A. duodenale parasites. Blood and stool samples were analyzed 14 days after starting piperazine treatment for A. duodenale infection. The medium concentration of IFNγ, IL-5, IL-12, and IL-13 in the serum samples with A. duodenale infection is higher than that of the control group. IFNγ, IL-5, IL-12, and IL-13 levels were significantly higher in the infected individuals (10.5±7.4 pg/ml, 14.6±5.1 pg/ml, 8.5±3.2 pg/ml and 13.6±7.5 pg/ml respectively) than the control group (4.7±2.4 pg/ml, 7.8±4.06 pg/ml, 6.3±3.4 pg/ml and 3.5±2.7 pg/ml respectively). Also, piperazine treatment can significantly reduce cytokines levels (IFN-γ: P=0.043, IL-5: P=0.02, and IL-12, p=0.001). This study shows that piperazine treatment can reduce cytokines profiles in patients with A. duodenale infection. |
format | Online Article Text |
id | pubmed-9126450 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Carol Davila University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-91264502022-06-01 Cytokine production in Ancylostoma duodenale infection Shlash, Shaimaa Abdulhussein Alzubaidi, Zubaida Falih Saleh, Huda Ali J Med Life Original Article Cytokine response to Ancylostoma duodenale (A. duodenale) infection was measured after starting treatments with piperazine. This study aims to determine the impact of cytokine production after infection with A. duodenale before and after treatment with piperazine. Blood and stool samples of 50 patients with A. duodenale infection and 28 healthy individuals (control) were collected. In this study, IFNγ, IL-5, IL-12, and IL-13 in serum (using ELISA-based methods) were measured. Stool samples were examined using the Kato-Katz technique to detect A. duodenale parasites. Blood and stool samples were analyzed 14 days after starting piperazine treatment for A. duodenale infection. The medium concentration of IFNγ, IL-5, IL-12, and IL-13 in the serum samples with A. duodenale infection is higher than that of the control group. IFNγ, IL-5, IL-12, and IL-13 levels were significantly higher in the infected individuals (10.5±7.4 pg/ml, 14.6±5.1 pg/ml, 8.5±3.2 pg/ml and 13.6±7.5 pg/ml respectively) than the control group (4.7±2.4 pg/ml, 7.8±4.06 pg/ml, 6.3±3.4 pg/ml and 3.5±2.7 pg/ml respectively). Also, piperazine treatment can significantly reduce cytokines levels (IFN-γ: P=0.043, IL-5: P=0.02, and IL-12, p=0.001). This study shows that piperazine treatment can reduce cytokines profiles in patients with A. duodenale infection. Carol Davila University Press 2022-04 /pmc/articles/PMC9126450/ /pubmed/35646178 http://dx.doi.org/10.25122/jml-2021-0383 Text en ©2022 JOURNAL of MEDICINE and LIFE https://creativecommons.org/licenses/by/3.0/This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/ (https://creativecommons.org/licenses/by/3.0/) ), which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Original Article Shlash, Shaimaa Abdulhussein Alzubaidi, Zubaida Falih Saleh, Huda Ali Cytokine production in Ancylostoma duodenale infection |
title | Cytokine production in Ancylostoma duodenale infection |
title_full | Cytokine production in Ancylostoma duodenale infection |
title_fullStr | Cytokine production in Ancylostoma duodenale infection |
title_full_unstemmed | Cytokine production in Ancylostoma duodenale infection |
title_short | Cytokine production in Ancylostoma duodenale infection |
title_sort | cytokine production in ancylostoma duodenale infection |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126450/ https://www.ncbi.nlm.nih.gov/pubmed/35646178 http://dx.doi.org/10.25122/jml-2021-0383 |
work_keys_str_mv | AT shlashshaimaaabdulhussein cytokineproductioninancylostomaduodenaleinfection AT alzubaidizubaidafalih cytokineproductioninancylostomaduodenaleinfection AT salehhudaali cytokineproductioninancylostomaduodenaleinfection |